Perigon Wealth Management’s ETF Series Solutions Trust Range Cancer Therapeutics ETF CNCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q1
Sell
-1,000
Closed -$32K 589
2020
Q4
$32K Buy
+1,000
New +$32K ﹤0.01% 867